UK Public Sector Contracts & Tenders

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Highly Specialised Services (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of providers and potential providers within this highly specialised area. All interested parties, including incumbent providers, are encouraged to register their interest and participate in the market engagement questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered to inform the commissioning approach.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), is inviting suitably qualified and experienced suppliers to respond to this Market Engagement exercise relating to the delivery of Selective internal radiation therapy (SIRT), which may also be called radioembolisation (RE), as an option for treating unresectable advanced HCC in adults. NICE Technology Appraisal 688, (SIRT), approves the use of SIRT (both SIR-Spheres and TheraSpheres products) as an option for treating unresectable advanced HCC in adults, only if the products are: • used for people with Child-Pugh grade A liver impairment when conventional transarterial therapies (transarterial embolisation and transarterial chemoembolisation) are inappropriate; and • the company provides SIR Spheres according to the commercial arrangement. NICE estimated that demand for this treatment will ramp-up over the next two years, reaching a steady state of around 340 patients by 2023/24, from a base of 80 in 2021-22. Reimbursement will be in 4 parts: • The work up procedure which groups to the core HRG YR54: Percutaneous Transluminal Embolisation of Peripheral Blood Vessel (1 per patient) • The treatment procedure which groups to the HRG YR57Z: Percutaneous, Chemoembolisation or Radioembolisation, of Lesion of Liver (estimated to be an average of c1.62 treatments per patient) • Unbundled radiotherapy SC28Z: Deliver a Fraction of Interstitial Radiotherapy (1 per treatment) • The cost of the microspheres (1 per treatment) The first 3 parts will be added to the fixed and variable elements of the 2022/23 Aligned Payment and Incentive agreements with NHS England Specialised Commissioning. The microspheres can be ordered through NHS Supply Chain as part of NHS England's Specialised Commissioning central procurement route and will be reimbursed via the Visible Cost Model (VCM) which is used for excluded device reimbursement. The estimated value for this contract is £26.7m* over 3 years *based on list price of microspheres.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of the providers and potential providers within this specialised area. Interested parties are encouraged to register their interest and complete the market questionnaire which will provide feedback to commissioners. NHS England intends to commission the services by splitting the requirement into 7 lots. NHS England is proposing that these lots will be split as follows (subject to the outcome of this Market Engagement Exercise) and providers are able to express an interest in providing services in more than one Lot: LOT 1 - East of England LOT 2 - London LOT 3 - Midlands LOT 4 - North East & Yorkshire LOT 5 - North West LOT 6 - South East LOT 7 - South West Penile Prosthesis surgery for end stage erectile dysfunction (ESED) is performed when a person is unable to gain or maintain an erection sufficient to allow sexual intercourse or sexual activity. Network arrangements will be considered to provide part of the Centre's penile prosthesis surgery service where surgeons from the network provider provide an in-reach service. "In reach" surgeons must be part of the specialist penile prosthesis MDT and must meet the minimum surgical requirements as outlined in the Service Specification (https://www.england.nhs.uk/wp-content/uploads/2021/03/1731-Service-Specification.pdf). This procurement is to cover the 7 NHS England and Improvement (NHS EI) regions as above. This service is expected to commence as soon as possible but in 2022/2023, depending on the outcome of the market engagement exercise. The anticipated contract duration for this service will be 3 years with an option to extend the contract by a further 12 month period, at the Commissioner's discretion. It is possible that as a result of this exercise, a formal tender process will not be required but instead a simpler provider selection process will be undertaken. Where it is noted that competition is absent, direct awards may be considered. All providers will be notified of next steps following the conclusion of this market engagement exercise. This notice is to advise prospective providers in the market of the commissioner's intention to commission a new service and to provide an opportunity to engage with and participate in a market engagement questionnaire. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach. NHS England (National) Specialised Commissioning is the contracting and commissioning authority for this service and will be willing to commission centres across England as part of a network arrangement. To register your interest and access the questionnaire, please follow this link: https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK The project reference is 52080 and the closing date for submission of the completed questionnaire is: 12 noon on Wednesday 18th May 2022.